Characterizing real-world functional outcomes in patients with geographic atrophy: An IRIS Registry Analysis

May 1, 2022
Research Lead:

Ted Leng, MD

SUO 2025: Real-world Outcomes in Patients with BCG-unresponsive, High-risk, Non-muscle Invasive Bladder Cancer with Carcinoma in Situ – A Chart Review Study in the American Urological Association’s Quality Registry

December 16, 2025
Read More

Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System: A Subgroup Analysis from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)

November 3, 2025
Read More

Contemporary Trends of Benign Prostatic Hyperplasia Procedures in the AUA Quality Registry: Are We Moving the Needle Toward More Minimally Invasive Treatments?

May 29, 2025
Read More

A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence

May 29, 2025
Read More

Who Progresses to Third-Line Therapies for Overactive Bladder? Trends From the AQUA Registry

May 29, 2025
Read More

Choice of First Medication Prescribed For Overactive Bladder Changes With Time: Trends From The AUA AQUA Registry

May 29, 2025
Read More

Factors Influencing Medication Selection for Management of Overactive Bladder: Trends and Insights From AUA Quality Registry

May 29, 2025
Read More

Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US

May 29, 2025
Read More

Early Outcomes After Initiation of Faricimab for Neovascular Age-Related Macular Degeneration

May 21, 2025
Read More

How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema”

December 13, 2024
Read More
Qdata

Talk to a Qdata Expert

Take a minute to submit your contact information and one of our team members will reach out to you.